Emanuele Naglieri

1.9k total citations
42 papers, 1.0k citations indexed

About

Emanuele Naglieri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Emanuele Naglieri has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Emanuele Naglieri's work include Cancer Immunotherapy and Biomarkers (13 papers), Renal cell carcinoma treatment (11 papers) and Ovarian cancer diagnosis and treatment (10 papers). Emanuele Naglieri is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Renal cell carcinoma treatment (11 papers) and Ovarian cancer diagnosis and treatment (10 papers). Emanuele Naglieri collaborates with scholars based in Italy, United States and United Kingdom. Emanuele Naglieri's co-authors include Ines Abbate, Antonella Daniele, Raffaele De Luca, Rosa Divella, Walter Ageno, Melina Verso, Sergio Bertoglio, Pasquale Parise, Francesco Paoletti and Giancarlo Agnelli and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Emanuele Naglieri

38 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emanuele Naglieri Italy	15	336	245	210	206	200	42	1.0k
A Catania Italy	23	232 0.7×	553 2.3×	197 0.9×	79 0.4×	332 1.7×	93	1.5k
Elrasheid A. H. Kheirelseid Ireland	15	221 0.7×	236 1.0×	287 1.4×	101 0.5×	232 1.2×	27	916
Abdurrahman Işıkdoğan Türkiye	19	537 1.6×	204 0.8×	204 1.0×	60 0.3×	424 2.1×	146	1.2k
Kyoung Ha Kim South Korea	17	325 1.0×	181 0.7×	199 0.9×	78 0.4×	240 1.2×	72	932
Herbert Stöger Austria	19	562 1.7×	198 0.8×	165 0.8×	61 0.3×	259 1.3×	68	1.1k
Nelly G. Adel United States	9	926 2.8×	155 0.6×	159 0.8×	223 1.1×	245 1.2×	27	1.4k
Sergio Siragusa Italy	26	242 0.7×	360 1.5×	360 1.7×	748 3.6×	195 1.0×	150	2.1k
Sung Hwa Bae South Korea	19	468 1.4×	168 0.7×	274 1.3×	103 0.5×	197 1.0×	101	1.2k
Sung‐Hyun Kim South Korea	17	371 1.1×	136 0.6×	213 1.0×	117 0.6×	223 1.1×	105	1.0k
Mustafa Altınbaş Türkiye	12	202 0.6×	103 0.4×	145 0.7×	268 1.3×	120 0.6×	47	670

Countries citing papers authored by Emanuele Naglieri

Since Specialization

Citations

This map shows the geographic impact of Emanuele Naglieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuele Naglieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuele Naglieri more than expected).

Fields of papers citing papers by Emanuele Naglieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuele Naglieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuele Naglieri. The network helps show where Emanuele Naglieri may publish in the future.

Co-authorship network of co-authors of Emanuele Naglieri

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuele Naglieri. A scholar is included among the top collaborators of Emanuele Naglieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuele Naglieri. Emanuele Naglieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lasorsa, Francesco, Savio Domenico Pandolfo, Monica Rutigliano, et al.. (2025). Histopathology and outcomes of non-metastatic renal cell carcinoma with inferior vena cava tumor thrombus: systematic review and meta-analysis. European Journal of Surgical Oncology. 51(12). 110491–110491. 1 indexed citations

Bove, Samantha, Francesca Arezzo, Gennaro Cormio, et al.. (2024). Explainable machine learning for predicting recurrence-free survival in endometrial carcinosarcoma patients. Frontiers in Artificial Intelligence. 7. 1388188–1388188.

Fanizzi, Annarita, Francesca Arezzo, Gennaro Cormio, et al.. (2024). An explainable machine learning model to solid adnexal masses diagnosis based on clinical data and qualitative ultrasound indicators. Cancer Medicine. 13(12). e7425–e7425. 4 indexed citations

Iacovelli, Roberto, Chiara Ciccarese, Matteo Brunelli, et al.. (2022). First line avelumab in PD-L1+ve metastatic or locally advanced urothelial cancer (aUC) patients unfit for cisplatin (cis): The ARIES trial.. Journal of Clinical Oncology. 40(6_suppl). 439–439. 4 indexed citations

Bersanelli, Melissa, Giulia Mazzaschi, Patrizia Giannatempo, et al.. (2021). Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group). Immunotherapy. 14(2). 107–114. 2 indexed citations

Fornarini, Giuseppe, Sara Elena Rebuzzi, Giuseppe Luigi Banna, et al.. (2021). Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort. ESMO Open. 6(3). 100118–100118. 43 indexed citations

Basso, Umberto, Camillo Porta, Ugo De Giorgi, et al.. (2020). 721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study. Annals of Oncology. 31. S566–S566.

Matteis, Elisabetta De, Gennaro Cormio, Emanuele Naglieri, et al.. (2019). ReOL - OLaparib in the REal World. A retrospective observational study to evaluate the impact of olaparib on the real-world treatment of BRCA carrier patients with recurrent ovarian cancer. European Journal of Gynaecological Oncology. 40(5). 759–764.

Calvani, Nicola, Franco Morelli, Emanuele Naglieri, et al.. (2019). Metronomic chemotherapy with cyclophosphamide plus low dose of corticosteroids in advanced castration-resistant prostate cancer across the era of taxanes and new hormonal drugs. Medical Oncology. 36(9). 80–80. 14 indexed citations

10.

Tommasi, Stefania, et al.. (2018). Standardization of CTC AR‐V7 PCR assay and evaluation of its role in castration resistant prostate cancer progression. The Prostate. 79(1). 54–61. 22 indexed citations

11.

Loizzi, Vera, G Gargano, Emanuele Naglieri, et al.. (2017). Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer. International Journal of Molecular Sciences. 18(9). 1967–1967. 75 indexed citations

12.

Divella, Rosa, Antonella Daniele, Antonio Mazzocca, et al.. (2017). ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer. Journal of Cancer. 8(6). 1000–1008. 17 indexed citations

13.

Divella, Rosa, Raffaele De Luca, Ines Abbate, Emanuele Naglieri, & Antonella Daniele. (2016). Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. Journal of Cancer. 7(15). 2346–2359. 247 indexed citations

14.

Chiarion‐Sileni, Vanna, Paola Del Bianco, Antonella Romanini, et al.. (2006). Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI – Mel.A.) [ISRCTN75125874]. BMC Cancer. 6(1). 44–44. 18 indexed citations

15.

Verso, Melina, Giancarlo Agnelli, Sergio Bertoglio, et al.. (2005). Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients. Journal of Clinical Oncology. 23(18). 4057–4062. 220 indexed citations

16.

Placido, Sabino De, Giovanni Scambia, Giovanni Di Vagno, et al.. (2004). Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study. Journal of Clinical Oncology. 22(13). 2635–2642. 118 indexed citations

17.

Naglieri, Emanuele, et al.. (1999). Cisplatin, Interleukin-2, Interferon-α and Tamoxifen in Metastatic Melanoma. A Phase II Study. Journal of Chemotherapy. 11(2). 150–155. 7 indexed citations

18.

Naglieri, Emanuele, et al.. (1998). Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma.. PubMed. 18(3B). 2021–6. 11 indexed citations

19.

Colucci, Giuseppe, et al.. (1998). Role of prognostic factors in the therapeutic strategy of primary gastric non Hodgkin's lymphomas.. PubMed. 149(921). 25–30. 4 indexed citations

20.

Maiello, Evaristo, Francesco Giotta, Francesco Giuliani, Emanuele Naglieri, & Giuseppe Colucci. (1991). Sequential methotrexate/5-fluorouracil in advanced colorectal cancer treatment. Journal of Surgical Oncology. 48(S2). 129–133. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact